Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)
Close on Nov 17, 2026Market cap $140.36MP/E –Yield –
Drugs Made In America Acquisition II cash
Cash and short-term investments held at the end of each period.
Drugs Made In America Acquisition II's cash was $118.23K at Sep 30, 2026. For fiscal 2025 it was $223, down 98.7% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $223 | -98.7% |
| FY2024 | Dec 31, 2024 | $17.04K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $118.23K | -62.5% |
| Q2 FY2026 | Jun 30, 2026 | $174.97K | +3882.1% |
| Q1 FY2026 | Mar 31, 2026 | $347.72K | +4873.8% |
| Q4 FY2025 | Dec 31, 2025 | $223 | -98.7% |
| Q3 FY2025 | Sep 30, 2025 | $315.09K | +162.4% |
| Q2 FY2025 | Jun 30, 2025 | $4.39K | – |
| Q1 FY2025 | Mar 31, 2025 | $6.99K | – |
| Q4 FY2024 | Dec 31, 2024 | $17.04K | – |
| Q3 FY2024 | Sep 30, 2024 | $120.07K | – |
See a number that looks wrong?